Marc Tessier-Lavigne

Marc Trevor Tessier-Lavigne (born December 18, 1959) is a Canadian-American neuroscientist who was the eleventh president of Stanford University.

Previously, he was a professor at the University of California, San Francisco and then president of Rockefeller University in New York City. He was formerly executive vice president for research and chief scientific officer at Genentech. As of 2021, he is on the boards of directors of Denali Therapeutics and Regeneron Pharmaceuticals, as well as the scientific advisory boards of Denali Therapeutics and Agios Pharmaceuticals.

In 2022, the Stanford board of trustees opened an investigation into allegations that Tessier-Lavigne might have been involved in fabricating results in articles published between 2001 and 2008, when he was working at Genentech. In July 2023, the trustees' report was released, finding that in several papers he co-authored "there was apparent manipulation of research data by others." Tessier-Lavigne then announced that he would be stepping down as president of Stanford, effective August 31, 2023. On April 23, 2024, it was announced that Tessier-Lavigne would take the role of CEO of a new AI biotech drug discovery startup, Xaira Therapeutics. Provided by Wikipedia